Author:
Trevisan Giusto,Errichetti Enzo,di Meo Nicola,Pinzani Caterina,Nan Katiuscia,Stinco Giuseppe
Abstract
Borrelia burgdorferi is highly susceptible to antibiotic treatment and the majority of patients profit from this treatment. Antibiotic selection, dose and route of administration, and duration of therapy for Lyme disease depend on the patient’s clinical manifestations and stage of disease, age, pregnancy status, as well as the presence of other concomitant diseases and/or allergies. Despite an appropriate antibiotic therapy, about 10-20% of patients may show persistent or recurrent symptoms ("post-treatment Lyme disease syndrome").
In the present paper we will briefly discuss the post-exposure prophylaxis, before going on to talk over the current therapeutic approach regarding the management of Lyme disease according to the stage of disease/clinical manifestations. Finally, we will discuss the main treatment-related phenomenon, the Jarisch-Herxheimer reaction, and the treatment modalities for special categories of patients, namely pregnant women, subjects suffering from post-treatment Lyme disease syndrome, possible Borrelia-associated skin manifestations, coinfections and Baggio-Yoshinary syndrome.
Publisher
Bentham Science Publishers Ltd.
Reference95 articles.
1. Vasudevan B, Chatterjee M.
Lyme borreliosis and skin.
Indian J Dermatol
2013;
58
(3)
: 167-74.
2. Nau R, Christen H-J, Eiffert H.
Lyme disease--current state of knowledge.
Dtsch Arztebl Int
2009;
106
(5)
: 72-81.
3. Biesiada G, Czepiel J, Leśniak MR, Garlicki A, Mach T.
Lyme disease: review.
Arch Med Sci
2012;
8
(6)
: 978-82.
[review].
4. Scarpa C, Trevisan G, Stinco G.
Lyme borreliosis.
Dermatol Clin
1994;
12
(4)
: 669-85.
5. Rizzoli A, Hauffe H, Carpi G, Vourc H G, Neteler M, Rosa R.
Lyme borreliosis in Europe.
Euro Surveill
2011;
16
(27)
: 1-8.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献